PT-2022-16255 · Unknown · Reversewall-Mds

Kuniyuki Iwashima · Published 2022-10-17 · Updated 2022-10-19 · CVE-2022-23769

Positive Technologies (AI Summary)

CVSS v3.1

9.8

Critical

Base vector

AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Name of the Vulnerable Software and Affected Versions reverseWall-MDS (affected versions not specified)

Description The issue is related to a remote code execution vulnerability due to insufficient user privilege verification. This allows remote attackers to exploit the vulnerability, potentially leading to the theft of accounts through remote code execution.

Recommendations At the moment, there is no information about a newer version that contains a fix for this vulnerability.

Improper Authentication

Weakness Enumeration

CWE-287

Related Identifiers

CVE-2022-23769

Affected Products

Reversewall-Mds

References · 3

• https://nvd.nist.gov/vuln/detail/CVE-2022-23769 · Security Note
• https://osv.dev/vulnerability/CVE-2022-23769 · Vendor Advisory
• https://krcert.or.kr/krcert/secNoticeView.do?bulletin_writing_sequence=66962 · Note